发明申请
US20130225488A1 Antidiabetic Comppounds 有权
抗糖尿病综合征

Antidiabetic Comppounds
摘要:
The present invention provides novel peptidomimetics, of formula (I), which primarily act as glucose dependent insulin secretagogues. Furthermore, it was found that these peptidomimetics showed glucagon receptor antagonistic activity, along with the GLP-1 receptor agonistic activity. A—Z1—Z2—Z3—Z4—Z5—Z6—Z7—Z8—Z9—Z10—Z11—B  (I)
公开/授权文献
信息查询
0/0